Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

Cited In for PubMed (Select 17298393)


Potent and tumor specific: arming bacteria with therapeutic proteins.

Van Dessel N, Swofford CA, Forbes NS.

Ther Deliv. 2015 Apr;6(3):385-99. doi: 10.4155/tde.14.113.


Quorum-sensing Salmonella selectively trigger protein expression within tumors.

Swofford CA, Van Dessel N, Forbes NS.

Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):3457-62. doi: 10.1073/pnas.1414558112. Epub 2015 Mar 3.


The N terminus of type III secretion needle protein YscF from Yersinia pestis functions to modulate innate immune responses.

Osei-Owusu P, Jessen Condry DL, Toosky M, Roughead W, Bradley DS, Nilles ML.

Infect Immun. 2015 Apr;83(4):1507-22. doi: 10.1128/IAI.02687-14. Epub 2015 Feb 2.


Multicopy integration of mini-Tn7 transposons into selected chromosomal sites of a Salmonella vaccine strain.

Roos K, Werner E, Loessner H.

Microb Biotechnol. 2015 Jan;8(1):177-87. doi: 10.1111/1751-7915.12187. Epub 2014 Dec 9.


Participation of the Salmonella OmpD porin in the infection of RAW264.7 macrophages and BALB/c mice.

Ipinza F, Collao B, Monsalva D, Bustamante VH, Luraschi R, Alegría-Arcos M, Almonacid DE, Aguayo D, Calderón IL, Gil F, Santiviago CA, Morales EH, Calva E, Saavedra CP.

PLoS One. 2014 Oct 31;9(10):e111062. doi: 10.1371/journal.pone.0111062. eCollection 2014.


Improved cytotoxic effects of Salmonella-producing cytosine deaminase in tumour cells.

Mesa-Pereira B, Medina C, Camacho EM, Flores A, Santero E.

Microb Biotechnol. 2015 Jan;8(1):169-76. doi: 10.1111/1751-7915.12153. Epub 2014 Sep 16.


Molecular imaging of biological gene delivery vehicles for targeted cancer therapy: beyond viral vectors.

Min JJ, Nguyen VH, Gambhir SS.

Nucl Med Mol Imaging. 2010 Apr;44(1):15-24. doi: 10.1007/s13139-009-0006-3. Epub 2010 Feb 26.


Bacterial delivery of Staphylococcus aureus α-hemolysin causes regression and necrosis in murine tumors.

St Jean AT, Swofford CA, Panteli JT, Brentzel ZJ, Forbes NS.

Mol Ther. 2014 Jul;22(7):1266-74. doi: 10.1038/mt.2014.36. Epub 2014 Mar 4.


Engineering of bacteria for the visualization of targeted delivery of a cytolytic anticancer agent.

Jiang SN, Park SH, Lee HJ, Zheng JH, Kim HS, Bom HS, Hong Y, Szardenings M, Shin MG, Kim SC, Ntziachristos V, Choy HE, Min JJ.

Mol Ther. 2013 Nov;21(11):1985-95. doi: 10.1038/mt.2013.183. Epub 2013 Aug 7.


Escherichia coli Nissle 1917 targets and restrains mouse B16 melanoma and 4T1 breast tumors through expression of azurin protein.

Zhang Y, Zhang Y, Xia L, Zhang X, Ding X, Yan F, Wu F.

Appl Environ Microbiol. 2012 Nov;78(21):7603-10. doi: 10.1128/AEM.01390-12. Epub 2012 Aug 24.


Development and application of an arabinose-inducible expression system by facilitating inducer uptake in Corynebacterium glutamicum.

Zhang Y, Shang X, Lai S, Zhang G, Liang Y, Wen T.

Appl Environ Microbiol. 2012 Aug;78(16):5831-8. doi: 10.1128/AEM.01147-12. Epub 2012 Jun 8.


Explicit hypoxia targeting with tumor suppression by creating an "obligate" anaerobic Salmonella Typhimurium strain.

Yu B, Yang M, Shi L, Yao Y, Jiang Q, Li X, Tang LH, Zheng BJ, Yuen KY, Smith DK, Song E, Huang JD.

Sci Rep. 2012;2:436. doi: 10.1038/srep00436. Epub 2012 Jun 1.


Identification of tumor-specific Salmonella Typhimurium promoters and their regulatory logic.

Leschner S, Deyneko IV, Lienenklaus S, Wolf K, Bloecker H, Bumann D, Loessner H, Weiss S.

Nucleic Acids Res. 2012 Apr;40(7):2984-94. doi: 10.1093/nar/gkr1041. Epub 2011 Dec 2.


Contribution of the PhoP/Q regulon to survival and replication of Salmonella enterica serovar Typhimurium in macrophages.

Thompson JA, Liu M, Helaine S, Holden DW.

Microbiology. 2011 Jul;157(Pt 7):2084-93. doi: 10.1099/mic.0.048926-0. Epub 2011 Apr 21.


Positively regulated bacterial expression systems.

Brautaset T, Lale R, Valla S.

Microb Biotechnol. 2009 Jan;2(1):15-30. doi: 10.1111/j.1751-7915.2008.00048.x. Epub 2008 Oct 15. Review.


A key role for E-cadherin in intestinal homeostasis and Paneth cell maturation.

Schneider MR, Dahlhoff M, Horst D, Hirschi B, Trülzsch K, Müller-Höcker J, Vogelmann R, Allgäuer M, Gerhard M, Steininger S, Wolf E, Kolligs FT.

PLoS One. 2010 Dec 14;5(12):e14325. doi: 10.1371/journal.pone.0014325.


Pathogenic bacteria as vaccine vectors: teaching old bugs new tricks.

Carleton HA.

Yale J Biol Med. 2010 Dec;83(4):217-22. Review.


Comparison of a regulated delayed antigen synthesis system with in vivo-inducible promoters for antigen delivery by live attenuated Salmonella vaccines.

Wang S, Li Y, Shi H, Sun W, Roland KL, Curtiss R 3rd.

Infect Immun. 2011 Feb;79(2):937-49. doi: 10.1128/IAI.00445-10. Epub 2010 Dec 6.


Engineering the perfect (bacterial) cancer therapy.

Forbes NS.

Nat Rev Cancer. 2010 Nov;10(11):785-94. doi: 10.1038/nrc2934. Epub 2010 Oct 14. Review.


Yersinia pestis with regulated delayed attenuation as a vaccine candidate to induce protective immunity against plague.

Sun W, Roland KL, Kuang X, Branger CG, Curtiss R 3rd.

Infect Immun. 2010 Mar;78(3):1304-13. doi: 10.1128/IAI.01122-09. Epub 2010 Jan 19.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk